Pierre‐Dominique Ghislain

Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel

Sima Halevy, Pierre‐Dominique Ghislain, Maja Mockenhaupt et al. · Journal of the American Academy of Dermatology · 2007 · 473 citations

Toxic Epidermal Necrolysis, Stevens-johnson Syndrome, Pathology +5

Treatment of severe drug reactions: Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis and Hypersensitivity syndrome

Pierre‐Dominique Ghislain, Jean‐Claude Roujeau · Dermatology Online Journal · 2002 · 260 citations

Toxic Epidermal Necrolysis, Drug Hypersensitivity, Allergy +15

Efficacy and safety of adalimumab every other week versus methotrexate once weekly in children and adolescents with severe chronic plaque psoriasis: a randomised, double-blind, phase 3 trial

Kim Papp, Diamant Thaçi, Danielle Marcoux et al. · The Lancet · 2017 · 147 citations

Systemic Treatment, Clinical Trials, Pediatrics +4

A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE study

Diamant Thaçi, J.‐P. Ortonne, Sergio Chimenti et al. · British Journal of Dermatology · 2010 · 111 citations

Topical Therapies, Medicine, Severe Psoriasis +11

Ustekinumab improves nail disease in patients with moderate‐to‐severe psoriasis: results from <scp>PHOENIX</scp> 1

Phoebe Rich, Marc Bourcier, Howard Sofen et al. · British Journal of Dermatology · 2013 · 110 citations · Full text